COURTNEY BLOCKER: Open Payments
NPI 1134534399 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$521 in 11 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $176 · 2025 $521
Food & beverage: $521
| Company | Payments | Amount |
|---|---|---|
| Calliditas Therapeutics US Inc. | 2 | $153 |
| AKEBIA THERAPEUTICS INC | 2 | $129 |
| GlaxoSmithKline, LLC. | 1 | $121 |
| Travere Therapeutics, Inc. | 1 | $24 |
| Vifor Pharma, Inc. | 1 | $21 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $21 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
| Ardelyx, Inc. | 1 | $16 |
Products named: TARPEYO, Vafseo, BENLYSTA, Veltassa, JARDIANCE, Kerendia, FARXIGA, IBSRELA.
Industry payments across NC — which companies pay providers there.
